Search results
Results From The WOW.Com Content Network
Coxsackie-induced cardiomyopathy is a potential result of virally induced myocarditis. This cardiomyopathy may present with symptoms such as chest pain, fatigue, heart failure, cardiogenic shock, arrhythmias or sudden death. [7] These symptoms are a by-product of sustained cardiac muscle damage.
Coxsackie B infection of the heart can lead to pericardial effusion. The development of insulin-dependent diabetes has recently been associated with recent enteroviral infection, particularly coxsackievirus B pancreatitis. This relationship is currently being studied further.
Coxsackie B is a group of six serotypes of coxsackievirus (CVB1-CVB6), a pathogenic enterovirus, that trigger illnesses ranging from a mild febrile rash to full-fledged pericarditis and myocarditis (coxsackievirus-induced cardiomyopathy). [1] [2] The genome of Coxsackie B virus consists of approximately 7,400 base pairs. [3]
Viral cardiomyopathy occurs when viral infections cause myocarditis with a resulting thickening of the myocardium and dilation of the ventricles. These viruses include Coxsackie B and adenovirus, echoviruses, influenza H1N1, Epstein–Barr virus, rubella (German measles virus), varicella (chickenpox virus), mumps, measles, parvoviruses, yellow fever, dengue fever, polio, rabies, and the ...
Nearly 90% of adults over age 20 in the United States are at risk of developing heart disease, an alarming new study suggests.. While the unexpectedly high number doesn't mean that the majority of ...
The coronavirus can damage the heart, according to a major new study which found abnormalities in the heart function of more than half of patients.
Patients with Coxsackie B4 virus have seemed to have herpangina, tonsillitis, and pharyngitis. [6] CB4 virus has caused transplacental infections in mice. Infection in the first couple weeks of gestation has been shown to be harmful for dams as well as the fetus, causing reduced litter sizes, abortion, or stillbirth.
A new study has revealed that roughly 90% of Americans may qualify as having stage 1 or higher cardiovascular-kidney-metabolic syndrome. This can end up leading to heart disease and kidney failure